You are here

Article Text

Article menu
Download PDFPDF
Research Article
Oral BCG vaccine in Crohn's disease.
  1. W R Burnham,
  2. J E Lennard-Jones,
  3. P Hecketsweiler,
  4. R Colin,
  5. Y Geffroy

    Abstract

    In a randomised double-blind trial over one year oral BCG has been compared with a control preparation in the treatment of chronic Crohn's disease. Overall assessment scores deteriorated in nine of 22 patients taking BCG, and 11 of 26 in the control group (P = 0.25); this deterioration was great enough to be regarded as a clinical relapse in three patients taking BCG and in seven taking the control preparation (P greater than 0.1). No significant benefit from oral BCG treatment has been demonstrated.

    https://doi.org/10.1136/gut.20.3.229

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.